{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:11:11Z","timestamp":1783642271945,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T00:00:00Z","timestamp":1540512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T00:00:00Z","timestamp":1540512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Kansas National Bio and Agro-Defense Facility Transition Fund"},{"name":"U.S. Department of Homeland Security (US) Center of Excellence for Emerging and Zoonotic Animal Diseases","award":["2010-ST061-AG0001"],"award-info":[{"award-number":["2010-ST061-AG0001"]}]},{"name":"Kansas Bioscience Authority (US) and Center of Excellence for Emerging and Zoonotic Animal Diseases matching funds","award":["BG2428"],"award-info":[{"award-number":["BG2428"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2019,2,1]]},"DOI":"10.1007\/s00705-018-4071-8","type":"journal-article","created":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T06:48:15Z","timestamp":1540536495000},"page":"359-370","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Evaluation of an African swine fever (ASF) vaccine strategy incorporating priming with an alphavirus-expressed antigen followed by boosting with attenuated ASF virus"],"prefix":"10.1007","volume":"164","author":[{"given":"Maria V.","family":"Murgia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Mogler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Certoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Monaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond R. R.","family":"Rowland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7195-785X","authenticated-orcid":false,"given":"Natasha N.","family":"Gaudreault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,26]]},"reference":[{"issue":"5","key":"4071_CR1","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1099\/jgv.0.001049","volume":"99","author":"C Alonso","year":"2018","unstructured":"Alonso C, Borca M, Dixon L, Revilla Y, Rodriguez F, Escribano JM, ICTV Report Consortium (2018) ICTV virus taxonomy profile: Asfarviridae. J Gen Virol 99(5):613\u2013614","journal-title":"J Gen Virol"},{"key":"4071_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/BF01309265","volume":"77","author":"E Tabares","year":"1983","unstructured":"Tabares E, Mart\u00ednez J, Mart\u00edn E, Escribano JM (1983) Proteins specified by African Swine Fever virus. IV. Glycoproteins and phosphoproteins. Arch Virol 77:167\u2013180","journal-title":"Arch Virol"},{"key":"4071_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/BF01317479","volume":"92","author":"JM Escribano","year":"1987","unstructured":"Escribano JM, Tabares E (1987) Proteins specified by African swine fever virus: V. Identification of immediate early, early and late proteins. Arch Virol 92:221\u2013232","journal-title":"Arch Virol"},{"key":"4071_CR4","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1099\/0022-1317-83-6-1331","volume":"83","author":"SD Kollnberger","year":"2002","unstructured":"Kollnberger SD, Gutierrez-Casta\u00f1eda B, Foster-Cuevas M, Corteyn A, Parkhouse RM (2002) Identification of the principal serological immunodeterminants of African swine fever virus by screening a virus cDNA library with antibody. J Gen Virol 83:1331\u20131342","journal-title":"J Gen Virol"},{"key":"4071_CR5","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1006\/viro.1998.9068","volume":"243","author":"P Gomez-Puertas","year":"1998","unstructured":"Gomez-Puertas P, Rodr\u00edguez F, Oviedo JM, Brun A, Alonso C, Escribano JM (1998) The African swine fever virus proteins p54 and p30 are involved in two distinct steps of virus attachment and both contribute to the antibody-mediated protective immune response. Virology 243:461\u2013471","journal-title":"Virology"},{"key":"4071_CR6","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.virol.2003.11.011","volume":"319","author":"JG Neilan","year":"2004","unstructured":"Neilan JG, Zsak L, Lu Z, Burrage TG, Kutish GF, Rock DL (2004) Neutralizing antibodies to African swine fever virus proteins p30, p54, and p72 are not sufficient for antibody-mediated protection. Virology 319:337\u2013342","journal-title":"Virology"},{"key":"4071_CR7","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1007\/s007050170056","volume":"146","author":"MG Barderas","year":"2001","unstructured":"Barderas MG, Rodr\u00edguez F, G\u00f3mez-Puertas P, Avil\u00e9s M, Beitia F, Alonso C et al (2001) Antigenic and immunogenic properties of a chimera of two immunodominant African swine fever virus proteins. Arch Virol 146:1681\u20131691","journal-title":"Arch Virol"},{"key":"4071_CR8","doi-asserted-by":"publisher","first-page":"e40942","DOI":"10.1371\/journal.pone.0040942","volume":"7","author":"JM Argilaguet","year":"2012","unstructured":"Argilaguet JM, P\u00e9rez-Mart\u00edn E, Nofrar\u00edas M, Gallardo C, Accensi F, Lacasta A et al (2012) DNA vaccination partially protects against African swine fever virus lethal challenge in the absence of antibodies. PLoS One 7:e40942","journal-title":"PLoS One"},{"key":"4071_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.antiviral.2013.02.005","volume":"98","author":"JM Argilaguet","year":"2013","unstructured":"Argilaguet JM, P\u00e9rez-Mart\u00edn E, L\u00f3pez S, Goethe M, Escribano JM, Giesow K et al (2013) BacMam immunization partially protects pigs against sublethal challenge with African swine fever virus. Antiviral Res 98:61\u201365","journal-title":"Antiviral Res"},{"key":"4071_CR10","unstructured":"Mogler M, Erdman M,Vander Veen R, Harris DLH, Owens G, Kamrud K et al (2009) Replicon particle PRRSV vaccine provides partial protection from challenge. In: Proceedings of the American Association of Swine Veterinarians,  40th annual meeting, pp 367\u2013368"},{"key":"4071_CR11","unstructured":"Mogler M, Vander Veen R, McVicker J, Russel B, Harris DLH (2010) Vaccination of pigs with PRRVENT or PrrSV-RP recombinant vaccines reduces viremia following heterologous challenge. In: Proceedings of the American Association of Swine Veterinarians,  41st annual meeting, pp 403\u2013404"},{"key":"4071_CR12","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1016\/j.vaccine.2012.01.030","volume":"30","author":"RL Vander Veen","year":"2012","unstructured":"Vander Veen RL, Loynachan AT, Mogler MA, Russell BJ, Harris DLH, Kamrud KI (2012) Safety, immunogenicity, and efficacy of an alphavirus replicon-based swine influenza virus hemagglutinin vaccine. Vaccine 30:1944\u20131950","journal-title":"Vaccine"},{"key":"4071_CR13","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1136\/vr.101741","volume":"173","author":"RL Vander Veen","year":"2013","unstructured":"Vander Veen RL, Mogler MA, Russell BJ, Loynachan AT, Harris DLH, Kamrud KI (2013) Haemagglutinin and nucleoprotein replicon particle vaccination of swine protects against the pandemic H1N1 2009 virus. Vet Rec 173:344","journal-title":"Vet Rec"},{"key":"4071_CR14","unstructured":"Mogler MA, Gander J, Harris DLH (2014) Development of an alphavirus RNA particle vaccine against portice epidemic diarrhea virus. In: Proceedings of the American Association of Swine Veterinarians, 45th annual meeting, pp 63\u201364"},{"key":"4071_CR15","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1099\/vir.0.80058-0","volume":"85","author":"FS Boinas","year":"2004","unstructured":"Boinas FS, Hutchings GH, Dixon LK, Wilkinson PJ (2004) Characterization of pathogenic and non-pathogenic African swine fever virus isolates from Ornithodoros erraticus inhabiting pig premises in Portugal. J Gen Virol 85:2177\u20132187","journal-title":"J Gen Virol"},{"key":"4071_CR16","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.1016\/j.vaccine.2011.04.052","volume":"29","author":"K King","year":"2011","unstructured":"King K, Chapman D, Argilaguet JM, Fishbourne E, Hutet E, Cariolet R, Hutchings G, Oura CA, Netherton CL, Moffat K, Taylor G, Le Potier MF, Dixon LK, Takamatsu HH (2011) Protection of European domestic pigs from virulent African isolates of African swine fever virus by experimental immunisation. Vaccine 29:4593\u20134600","journal-title":"Vaccine"},{"key":"4071_CR17","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1111\/tbed.12303","volume":"63","author":"LK Mulumba-Mfumu","year":"2016","unstructured":"Mulumba-Mfumu LK, Goatley LC, Saegerman C, Takamatsu HH, Dixon LK (2016) Immunization of African indigenous pigs with attenuated genotype I African swine fever virus OURT88\/3 induces protection against challenge with virulent strains of genotype I. Transbound Emerg Dis 63:e323\u2013e327","journal-title":"Transbound Emerg Dis"},{"key":"4071_CR18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.virol.2013.04.028","volume":"443","author":"CC Abrams","year":"2013","unstructured":"Abrams CC, Goatley L, Fishbourne E, Chapman D, Cooke L, Oura CA, Netherton CL, Takamatsu HH, Dixon LK (2013) Deletion of virulence associated genes from attenuated African swine fever virus isolate OUR T88\/3 decreases its ability to protect against challenge with virulent virus. Virology 443:99\u2013105","journal-title":"Virology"},{"key":"4071_CR19","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.virol.2006.10.049","volume":"360","author":"KI Kamrud","year":"2007","unstructured":"Kamrud KI, Custer M, Dudek JM, Owens G, Alterson KD, Lee JS et al (2007) Alphavirus replicon approach to promoterless analysis of IRES elements. Virology 360:376\u2013387","journal-title":"Virology"},{"key":"4071_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/B978-012465330-6\/50003-8","volume-title":"Virology methods manual","author":"JC Hierholzer","year":"1996","unstructured":"Hierholzer JC, Killington RA (1996) 2\u2014Virus isolation and quantitation A2\u2014Mahy, Brian WJ. In: Kangro HO (ed) Virology methods manual. Academic Press, London, pp 25\u201346. https:\/\/doi.org\/10.1016\/B978-012465330-6\/50003-8\n                           (Prickett J, Simer R)"},{"key":"4071_CR21","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1177\/104063870802000203","volume":"20","author":"J Christopher-Hennings","year":"2008","unstructured":"Christopher-Hennings J, Yoon K-J, Evans RB, Zimmerman JJ (2008) Detection of Porcine reproductive and respiratory syndrome virus infection in porcine oral fluid samples: a longitudinal study under experimental conditions. J Vet Diagn Investig 20:156\u2013163","journal-title":"J Vet Diagn Investig"},{"key":"4071_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0166-0934(02)00189-1","volume":"107","author":"DP King","year":"2003","unstructured":"King DP, Reid SM, Hutchings GH, Grierson SS, Wilkinson PJ, Dixon LK, Bastos AD, Drew TW (2003) Development of a TaqMan PCR assay with internal amplification control for the detection of African swine fever virus. J Virol Methods 107:53\u201361","journal-title":"J Virol Methods"},{"key":"4071_CR23","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1110\/ps.04618904","volume":"13","author":"A-M Catanzariti","year":"2004","unstructured":"Catanzariti A-M, Soboleva TA, Jans DA, Board PG, Baker RT (2004) An efficient system for high-level expression an easy purification of authentic recombinant proteins. Protein Sci 13:1331\u20131339","journal-title":"Protein Sci"},{"key":"4071_CR24","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1016\/j.febslet.2008.08.031","volume":"582","author":"B Hernaez","year":"2008","unstructured":"Hernaez B, Escribano JM, Alonso C (2008) African swine fever virus protein p30 interaction with heterogeneous nuclear ribonucleoprotein K (hnRNP-K) during infection. FEBS Lett 582:3275\u20133280","journal-title":"FEBS Lett"},{"key":"4071_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0166-0934(96)02140-4","volume":"64","author":"JM Oviedo","year":"1997","unstructured":"Oviedo JM, Rodriguez F, Gomez-Puertas P, Brun A, Gomez N, Alonso Cand Escribano JM (1997) High level expression of the major antigenic African swine fever virus proteins p54 and p30 in baculovirus and their potential use as diagnostic reagents. J Virol Methods 64:27\u201335","journal-title":"J Virol Methods"},{"issue":"5","key":"4071_CR26","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1128\/jvi.67.5.2475-2485.1993","volume":"67","author":"FJ Prados","year":"1993","unstructured":"Prados FJ, Vinuela E, Alcami A (1993) Sequence and characterization of the major early phosphoprotein p32 of African swine fever virus. J Virol 67(5):2475\u20132485","journal-title":"J Virol"},{"key":"4071_CR27","doi-asserted-by":"crossref","first-page":"5689","DOI":"10.1128\/jvi.70.8.5689-5694.1996","volume":"70","author":"P Gomez-Puertas","year":"1996","unstructured":"Gomez-Puertas P, Rodr\u00edguez F, Oviedo JM, Ramiro-Ib\u00e1\u00f1ez F, Ruiz-Gonzalvo F, Alonso C et al (1996) Neutralizing antibodies to different proteins of African swine fever virus inhibit both virus attachment and internalization. J Virol 70:5689\u20135694","journal-title":"J Virol"},{"key":"4071_CR28","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.virusres.2012.11.009","volume":"173","author":"HH Takamatsu","year":"2013","unstructured":"Takamatsu HH, Denyer MS, Lacasta A, Stirling CM, Argilaguet JM, Netherton CL, Oura CA, Martins C, Rodriguez F (2013) Cellular immunity in ASFV responses. Virus Res 173:110\u2013121","journal-title":"Virus Res"},{"key":"4071_CR29","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1099\/vir.0.81038-0","volume":"86","author":"CA Oura","year":"2005","unstructured":"Oura CA, Denyer MS, Takamatsu H, Parkhouse RM (2005) In vivo depletion of CD8+ T lymphocytes abrogates protective immunity to African swine fever virus. J Gen Virol 86:2445\u20132450","journal-title":"J Gen Virol"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00705-018-4071-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-018-4071-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-018-4071-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:18:33Z","timestamp":1744175913000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00705-018-4071-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,26]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2,1]]}},"alternative-id":["4071"],"URL":"https:\/\/doi.org\/10.1007\/s00705-018-4071-8","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,26]]},"assertion":[{"value":"14 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Experiments involving animals and viruses were performed in accordance with the Federation of Animal Science Societies Guide for the Care and Use of Agricultural Animals in Research and Teaching, the USDA Animal Welfare Act and Animal Welfare Regulations, and were approved by the Kansas State University animal care and use committees and institutional biosafety committees. This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}